Tom C. Hobman

Affiliations: 
Cell Biology University of Alberta, Edmonton, Alberta, Canada 
Area:
Cell Biology
Google:
"Tom Hobman"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Makio T, Zhang K, Love N, et al. (2024) SARS-CoV-2 Orf6 is positioned in the nuclear pore complex by Rae1 to control nucleo-cytoplasmic transport. Molecular Biology of the Cell. mbcE23100386
Chen J, Farraj RA, Velazquez DL, et al. (2023) Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease. The Journal of Biological Chemistry. 105341
Lodge R, Xu Z, Eklund M, et al. (2023) MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages. Mbio. e0195023
Lopez-Orozco J, Fayad N, Khan JQ, et al. (2023) The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2. Journal of Molecular Biology. 168170
Girgis S, Xu Z, Oikonomopoulos S, et al. (2022) Evolution of naturally arising SARS-CoV-2 defective interfering particles. Communications Biology. 5: 1140
Xu Z, Choi JH, Dai DL, et al. (2022) SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation. Proceedings of the National Academy of Sciences of the United States of America. 119: e2204539119
Airo AM, Felix-Lopez A, Mancinelli V, et al. (2022) Flavivirus Capsid Proteins Inhibit the Interferon Response. Viruses. 14
Ishida R, Cole J, Lopez-Orozco J, et al. (2021) Mayaro Virus Non-Structural Protein 2 Circumvents the Induction of Interferon in Part by Depleting Host Transcription Initiation Factor IIE Subunit 2. Cells. 10
Knoblach B, Ishida R, Hobman TC, et al. (2021) Peroxisomes exhibit compromised structure and matrix protein content in SARS-CoV-2-infected cells. Molecular Biology of the Cell. mbcE21020074
Limonta D, Dyna-Dagman L, Branton W, et al. (2021) Nodosome inhibition as a novel broad-spectrum antiviral strategy against arboviruses, enteroviruses and SARS-CoV-2. Antimicrobial Agents and Chemotherapy
See more...